A news item in the Other News to Note section of the Feb. 6, 2002, issue of BioWorld Today should have stated Xenova Group plc’s anticancer agent XR11576 is licensed to Millennium Pharmaceuticals Inc.

Editor’s Note: The correction has been made in BioWorld Online.